BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 17982156)

  • 1. Plasma androgen concentrations and risk of incident ovarian cancer.
    Tworoger SS; Lee IM; Buring JE; Hankinson SE
    Am J Epidemiol; 2008 Jan; 167(2):211-8. PubMed ID: 17982156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-like growth factors and ovarian cancer risk: a nested case-control study in three cohorts.
    Tworoger SS; Lee IM; Buring JE; Pollak MN; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1691-5. PubMed ID: 17684148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Kaaks R; Berrino F; Key T; Rinaldi S; Dossus L; Biessy C; Secreto G; Amiano P; Bingham S; Boeing H; Bueno de Mesquita HB; Chang-Claude J; Clavel-Chapelon F; Fournier A; van Gils CH; Gonzalez CA; Gurrea AB; Critselis E; Khaw KT; Krogh V; Lahmann PH; Nagel G; Olsen A; Onland-Moret NC; Overvad K; Palli D; Panico S; Peeters P; Quirós JR; Roddam A; Thiebaut A; Tjønneland A; Chirlaque MD; Trichopoulou A; Trichopoulos D; Tumino R; Vineis P; Norat T; Ferrari P; Slimani N; Riboli E
    J Natl Cancer Inst; 2005 May; 97(10):755-65. PubMed ID: 15900045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
    Eliassen AH; Missmer SA; Tworoger SS; Spiegelman D; Barbieri RL; Dowsett M; Hankinson SE
    J Natl Cancer Inst; 2006 Oct; 98(19):1406-15. PubMed ID: 17018787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association of plasma DHEA and DHEA sulfate with breast cancer risk in predominantly premenopausal women.
    Tworoger SS; Missmer SA; Eliassen AH; Spiegelman D; Folkerd E; Dowsett M; Barbieri RL; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):967-71. PubMed ID: 16702378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition.
    Kaaks R; Rinaldi S; Key TJ; Berrino F; Peeters PH; Biessy C; Dossus L; Lukanova A; Bingham S; Khaw KT; Allen NE; Bueno-de-Mesquita HB; van Gils CH; Grobbee D; Boeing H; Lahmann PH; Nagel G; Chang-Claude J; Clavel-Chapelon F; Fournier A; Thiébaut A; González CA; Quirós JR; Tormo MJ; Ardanaz E; Amiano P; Krogh V; Palli D; Panico S; Tumino R; Vineis P; Trichopoulou A; Kalapothaki V; Trichopoulos D; Ferrari P; Norat T; Saracci R; Riboli E
    Endocr Relat Cancer; 2005 Dec; 12(4):1071-82. PubMed ID: 16322344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer.
    Tworoger SS; Eliassen AH; Sluss P; Hankinson SE
    J Clin Oncol; 2007 Apr; 25(12):1482-8. PubMed ID: 17372279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma adrenal androgens and risk of breast cancer in premenopausal women.
    Page JH; Colditz GA; Rifai N; Barbieri RL; Willett WC; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):1032-6. PubMed ID: 15184260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgens and prostate cancer risk: a prospective study.
    Wirén S; Stocks T; Rinaldi S; Hallmans G; Bergh A; Stenman UH; Kaaks R; Stattin P
    Prostate; 2007 Aug; 67(11):1230-7. PubMed ID: 17562541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-reactive protein concentrations and subsequent ovarian cancer risk.
    McSorley MA; Alberg AJ; Allen DS; Allen NE; Brinton LA; Dorgan JF; Pollak M; Tao Y; Helzlsouer KJ
    Obstet Gynecol; 2007 Apr; 109(4):933-41. PubMed ID: 17400857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caffeine, alcohol, smoking, and the risk of incident epithelial ovarian cancer.
    Tworoger SS; Gertig DM; Gates MA; Hecht JL; Hankinson SE
    Cancer; 2008 Mar; 112(5):1169-77. PubMed ID: 18213613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgens and breast cancer in premenopausal women.
    Secreto G; Toniolo P; Pisani P; Recchione C; Cavalleri A; Fariselli G; Totis A; Di Pietro S; Berrino F
    Cancer Res; 1989 Jan; 49(2):471-6. PubMed ID: 2521298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intake of folate and related nutrients in relation to risk of epithelial ovarian cancer.
    Tworoger SS; Hecht JL; Giovannucci E; Hankinson SE
    Am J Epidemiol; 2006 Jun; 163(12):1101-11. PubMed ID: 16554344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of oral contraceptive use, other contraceptive methods, and infertility with ovarian cancer risk.
    Tworoger SS; Fairfield KM; Colditz GA; Rosner BA; Hankinson SE
    Am J Epidemiol; 2007 Oct; 166(8):894-901. PubMed ID: 17656616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testosterone/androstenedione ratio in the evaluation of women with ovarian androgen excess.
    Wiebe RH; Morris CV
    Obstet Gynecol; 1983 Mar; 61(3):279-84. PubMed ID: 6296743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between reproductive and menstrual factors and postmenopausal androgen concentrations.
    Chubak J; Tworoger SS; Yasui Y; Ulrich CM; Stanczyk FZ; McTiernan A
    J Womens Health (Larchmt); 2005 Oct; 14(8):704-12. PubMed ID: 16232102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum follicle-stimulating hormone and risk of epithelial ovarian cancer in postmenopausal women.
    Arslan AA; Zeleniuch-Jacquotte A; Lundin E; Micheli A; Lukanova A; Afanasyeva Y; Lenner P; Krogh V; Muti P; Rinaldi S; Kaaks R; Berrino F; Hallmans G; Toniolo P
    Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1531-5. PubMed ID: 14693749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recreational physical activity and sedentary behavior in relation to ovarian cancer risk in a large cohort of US women.
    Patel AV; Rodriguez C; Pavluck AL; Thun MJ; Calle EE
    Am J Epidemiol; 2006 Apr; 163(8):709-16. PubMed ID: 16495470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of incident ovarian cancer.
    Tworoger SS; Lee IM; Buring JE; Rosner B; Hollis BW; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):783-8. PubMed ID: 17416771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum dehydroepiandrosterone and dehydroepiandrosterone sulfate and the subsequent risk of developing colon cancer.
    Alberg AJ; Gordon GB; Hoffman SC; Comstock GW; Helzlsouer KJ
    Cancer Epidemiol Biomarkers Prev; 2000 May; 9(5):517-21. PubMed ID: 10815698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.